Literature DB >> 9781943

Thymoma: prognostic factors and treatment outcomes.

S Gripp1, K Hilgers, R Wurm, G Schmitt.   

Abstract

BACKGROUND: The objective of this study was to establish prognostic factors for thymoma and determine the impact of surgery with or without postoperative radiotherapy.
METHODS: Seventy patients treated at the University Hospital Düsseldorf during the period 1954-1991 were retrospectively studied. All thymoma patients underwent surgery, 22 received postoperative radiotherapy, and 3 also received chemotherapy. According to thymoma staging as described previously by Masaoka et al., 21% were Stage I, 26% Stage II, 43% Stage III, 7% Stage IVA, and 3% Stage IVB. Lymphocytic type disease was found in 36% of patients, lymphoepithelial type in 33%, epithelial type in 23%, and spindle cell type in 9%. The relevance of Karnofsky performance status (KPS), gender, age, myasthenia gravis, histology, tumor size, and stage to survival was determined by univariate analysis, and their independent significance was tested by multivariate analysis. Survival rates were calculated using the Kaplan-Meier method and the log rank test.
RESULTS: In univariate analysis, KPS (P < 0.001), histologic type (P=0.0093), and stage (P=0.0001) proved to be significant predictors of overall survival. Spindle cell type was associated with the best and epithelial type the worst prognosis; patients with the latter type had a 5-year survival rate of 30%. Multivariate analysis revealed that stage, histology, and KPS were predictive of overall survival. In Stages III and IV, relapses were reduced by postoperative radiotherapy from 50% to 20%. The site of relapse was outside the irradiated area in 80% of patients. Disease free survival (P=0.36) and median survival (P=0.72) of patients with completely resected advanced thymomas did not differ from that for patients with incompletely resected tumors who received radiotherapy.
CONCLUSIONS: Postoperative radiotherapy can improve local control in patients with advanced thymoma. Survival after incomplete resection is not compromised when postoperative radiotherapy is employed. KPS should be considered an important prognostic factor in future studies.

Entities:  

Mesh:

Year:  1998        PMID: 9781943

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  13 in total

1.  Bilateral video-assisted thoracoscopic thymectomy has a surgical extent similar to that of transsternal extended thymectomy with more favorable early surgical outcomes for myasthenia gravis patients.

Authors:  Chang Young Lee; Dae Joon Kim; Jin Gu Lee; In Kyu Park; Mi Kyung Bae; Kyung Young Chung
Journal:  Surg Endosc       Date:  2010-08-19       Impact factor: 4.584

2.  Thymoma. Analysis of prognostic factors.

Authors:  M Sonobe; M Nakagawa; M Ichinose; N Ikegami; M Nagasawa; T Shindo
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2001-01

3.  Only when all contribute their firewood can they build up a big fire.

Authors:  Marcelo F Benveniste; Edith M Marom
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

Review 4.  Thymoma and thymic carcinoma: an update of the WHO Classification 2004.

Authors:  Philipp Ströbel; Alexander Marx; Andreas Zettl; Hans Konrad Müller-Hermelink
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

5.  Multimodality treatment of stage II thymic tumours.

Authors:  Carolina Carillo; Daniele Diso; Sara Mantovani; Ylenia Pecoraro; Tiziano De Giacomo; Anna Maria Ciccone; Camilla Poggi; Flavia Longo; Raffaele Cassese; Vincenzo Tombolini; Erino Angelo Rendina; Federico Venuta; Marco Anile
Journal:  J Thorac Dis       Date:  2017-08       Impact factor: 2.895

6.  Comparing the safety and efficacy of thoracoscopic surgery and thoracotomy for thymoma: a systematic review and meta-analysis.

Authors:  Ling Lv; Wenya Li; Wanfu Men; Zhenghua Liu; Chenggang Jiang
Journal:  Gland Surg       Date:  2021-12

7.  Encapsulated thymoma metastasizing to a pectoralis major muscle.

Authors:  Yasuhisa Ohde; Tomoyuki Yokose; Junji Yoshida; Taketoshi Matsumoto; Kanji Nagai
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2002-06

Review 8.  Chemotherapy for thymic carcinoma and advanced thymoma in adults.

Authors:  Mao Ling Wei; Deying Kang; Lijia Gu; Meng Qiu; Liao Zhengyin; Yanming Mu
Journal:  Cochrane Database Syst Rev       Date:  2013-08-23

9.  Postoperative radiotherapy and tumor recurrence after complete resection of stage II/III thymic tumor: a meta-analysis of cohort studies.

Authors:  Jietao Ma; Xin Sun; Letian Huang; Zhicheng Xiong; Meng Yuan; Shuling Zhang; Cheng-Bo Han
Journal:  Onco Targets Ther       Date:  2016-07-22       Impact factor: 4.147

10.  Clinical significance of age at diagnosis among patients with thymic epithelial tumors: a population-based study.

Authors:  Mina Liu; Changlu Wang; Lanting Gao; Changxing Lv; Xiaolong Fu
Journal:  Aging (Albany NY)       Date:  2020-03-30       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.